Spain detects first case of Brazil coronavirus variant

Image of the ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Credit: CDC

Madrid authorities on Friday confirmed the first case in the region of the Brazilian variant of coronavirus, which is feared to be particularly infectious, in the region.

A 44-year-old man who arrived at Madrid’s airport on January 29 tested positive for the coronavirus and subsequent lab tests confirmed he had caught the new strain, the regional government of Madrid said in a statement.

The case is the first report in Spain of the variant, blamed for a disastrous surge in infections in the Brazilian city of Manaus.

The announcement came three days after Spain restricted arrivals by air from Brazil and South Africa to curb the spread of new strains.

Madrid has since the end of December also restricted arrivals from Britain because of the discovery of a new strain there last year.

Health authorities are concerned that new of the virus may spread more easily or could contain mutations which allow the virus to evade the effects of vaccines.

At least two cases of the South African variant have so far been detected in Spain and around 450 cases of the British variant.

Spain has been hard-hit by the pandemic, recording over 61,000 deaths from nearly three million cases so far.


Follow the latest news on the coronavirus (COVID-19) outbreak


© 2021 AFP

Citation:
Spain detects first case of Brazil coronavirus variant (2021, February 5)
retrieved 5 February 2021
from https://medicalxpress.com/news/2021-02-spain-case-brazil-coronavirus-variant.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Health News

mRNA vaccine more effective booster to ChAdOx1 nCoV-19

(HealthDay)—Use of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination is more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination, according to a study published online Oct. 17 in The Lancet Regional Health: Europe. Peter Nordström, M.D., Ph.D., from Umeå University in Sweden, and colleagues examined the effectiveness of heterologous prime-boost COVID-19 vaccination among individuals in […]

Read More
Health News

Moving monoclonal antibody treatments for COVID from hospital to home

(HealthDay)—Antibody infusions help keep high-risk COVID-19 patients out of the hospital, but getting the therapy can be a challenge. One U.S. health system has found a creative way to address the problem: home infusions administered by paramedics. They delivered antibody infusions to 144 COVID-19 patients in their homes over three months earlier this year. Most—about […]

Read More
Health News

Most kids newly diagnosed with ADHD aren’t getting best care

(HealthDay)—Preschoolers with attention deficit hyperactivity disorder (ADHD) rarely receive the gold-standard treatment recommended by the American Academy of Pediatrics (AAP) for their condition, a new study reports. The AAP recommends a behavioral therapy technique called “parent training in behavior management,” or PTBM, as first-line treatment for ADHD kids ages 4 and 5. But only 1 […]

Read More